PD-0250 Therapeutic use of Linac-based SRS in malignant spasticity: early results from a prospective trial. (May 2022) - Nicosia, L.; Avesani, R.; Rossato, E.; Ferrari, F.; Cuccia, F.; Figlia, V.; Giaj-Levra, N.; Mazzola, R.; Ricchetti, F.; Rigo, M.; Attinà, G.; Vitale, C.; et al.